Wednesday, April 12, 2017

The Digital Health Update by Paul Sonnier ⋅ Apr 13, 2017 ⋅ #270

I made this announcement to 55,007 members of the Digital Health group on LinkedIn. If you’re on LinkedIn, please do join the group, which allows you to opt in to receiving these announcements in addition to connecting with thousands of other global stakeholders in digital health. Note that I will continue to update this announcement up until sending out the final version via LinkedIn. I’m also now using Constant Contact to send an html and image-rich version of my announcements. You can subscribe to that version here.

The Digital Health Update by Paul Sonnier ⋅ Apr 13, 2017 ⋅ #270

Dear Group,

In this week’s Update (sent first to subscribers of my Constant Contact email newsletter) I highlight the “Surfer Biome Project”, the U.S Dept of Veterans Affairs (VA) use of predictive analytics to identify and support suicidal veterans, a research report (published in Nature Medicine) on translating genome editing to the clinic and, finally, the field of “digital therapeutics”, an important area of digital health.

I’ve also added supporting information on my definition of digital health vis-à-vis why I include genomics. As inspiration and corroboration of my rationale, I feature two key quotes from Dr. Eric Topol and J. Craig Venter: http://storyofdigitalhealth.com/definition

Read my latest newsletter: http://conta.cc/2pdUsmx

Surfer and doctoral candidate Cliff Kapono and the University of California, San Diego (UCSD) Center for Microbiome Innovation are spearheading the “Surfer Biome Project“, an effort aimed at examining the microbiomes of surfers around the world. By collecting, sequencing the DNA, and mapping the microbial communities found in samples from surfers’ bodies (and even their surfboards), Cliff hopes to see if the oceans spread antibiotic-resistant organisms to us.

In big news for direct-to-consumer (DTC) Personal Genome Service Genetic Health Risk (GHR) testing services, the FDA has given the green light to 23andMe to tell consumers if they have an increased risk of developing ten different diseases, including Alzheimer’s and Parkinson’s. In a statement, Dr. Jeffrey Shuren, head of the FDA’s Center for Devices and Radiological Health, said that “Consumers can now have direct access to certain genetic risk information, But it is important that people understand that genetic risk is just one piece of the bigger puzzle—it does not mean they will or won’t ultimately develop a disease.”

The U.S Dept of Veterans Affairs (VA) is using predictive analytics to identify and support suicidal veterans. According to a statement by the VA, “recent research suggests that 20 veterans die by suicide each day, putting veterans at even greater risk than the general public. Using a new predictive model, “REACH VET” analyzes existing data from veterans’ health records to identify those at a statistically elevated risk for suicide, hospitalization, illness, or other adverse outcomes. This allows VA to provide pre-emptive care and support for veterans, in some cases before a veteran even has suicidal thoughts.”

In what Dr. Eric Topol calls “a timely and impressive review“, Nature Medicine has published a research report “Refining strategies to translate genome editing to the clinic”. Recent progress in developing programmable nucleases (e.g. CRISPR), have paved the way for gene editing to enter clinical practice. Several clinical gene-editing trials, both ex vivo and in vivo, have been initiated in the past 2 years, including studies that aim to knockout genes as well as to add therapeutic transgenes. Here we discuss the advances made in the gene-editing field in recent years, and specify priorities that need to be addressed to expand therapeutic genome editing to further disease entities

In an article by Chrissy Farr in MIT’s Tech Review titled “Can “Digital Therapeutics” Be as Good as Drugs?“, there’s evident confusion about the fact that “digital health” is an overarching term for “digital medicine” and “digital therapeutics”, not a parallel term.  Peter Hames, CEO of Big Health, says  “It’s still a fluid space that everyone is trying to categorize.” Not exactly, as Farr explains: “About a dozen startups now call themselves digital therapeutics providers, and say they’re distinct from the rest of the digital health market of activity monitors, smart scales, and sleep trackers.” Operative phrase: “the rest of the digital health market”.

FEATURED EVENTS
Talkspace’s Reshaping Behavioral Health in the Workplace
April 25th in San Francisco – Save 30% using code DIGITALHEALTH-30

Dell EMC Healthcare Think Tank 2017
Apr 18 in Phoenix, AZ

Digital Health World Congress 2017 takes place May 23-24 in London, UK.
Complete list of global events

Copyright © 2017 Paul Sonnier

Follow me on Twitter @Paul_Sonnier for all the news I share each day.

SERVICES OFFERED: ADVERTISING, EXECUTIVE MANAGEMENT STRATEGY CONSULTING, AND KEYNOTE SPEAKING
If you are a digital health company, event organizer, or provider of other relevant solutions or services you can advertise in my announcements, on my website, and Twitter. Doing so puts you in front of 50,000+ targeted global prospects each week. I also provide strategic consulting and keynote speaking. Contact me for my media kit, standard plans, and pricing.

Paul Sonnier
Keynote Speaker ⋅ Management Consultant ⋅ Social Entrepreneur
Contributing Editor, Innovation & Tech Today
Founder, Digital Health group on LinkedIn ⋅ 50,000+ members
Creator, Story of Digital Health
Facebook: StoryOfDigitalHealth
Instagram: @StoryofDigitalHealth
Twitter: @Paul_Sonnier
San Diego, CA, USA

 

StoryofDigitalHealthLogo

 

The post The Digital Health Update by Paul Sonnier ⋅ Apr 13, 2017 ⋅ #270 appeared first on Paul Sonnier - Story of Digital Health.



from Paul Sonnier – Story of Digital Health http://storyofdigitalhealth.com/digital-health-update-paul-sonnier-%e2%8b%85-apr-13-2017-%e2%8b%85-270/
via IFTTT

No comments:

Post a Comment